Author of the publication

Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation

, , , , , , , , , , , and . Cell Death & Disease 2021 12:8 12 (8): 1--12 (August 2021)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism, , , , , , , , and . Cell Death & Disease (2018)Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM, , , , , and . Cells 2021, Vol. 10, Page 1182 10 (5): 1182 (May 2021)Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist, , , , , , , , , and . Cell Death & Disease 12 (7): 647 (July 2021)Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation, , , , , , , , , and 2 other author(s). Cell Death & Disease 2021 12:8 12 (8): 1--12 (August 2021)Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide, , , , , , and . Oncotarget 7 (38): 61295-61311 (2016)Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma, , , , , , , , , and 4 other author(s). Cancers 11 (12): 2005 (2019)